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To orchestrate the genomic response to cellular stress signals, p53 recognizes and binds to DNA 
containing specific and well-characterized p53-responsive elements (REs). Differences in RE sequences 
can strongly affect the p53 transactivation capacity and occur even between closely related species. 
Therefore, the identification and characterization of a species-specific p53 Binding sistes (BS) consensus 
sequence and of the associated target genes may help to provide new insights into the evolution of 
the p53 regulatory networks across different species. Although p53 functions were studied in a wide 
range of species, little is known about the p53-mediated transcriptional signature in Danio rerio. Here, 
we designed and biochemically validated a computational approach to identify novel p53 target genes 
in Danio rerio genome. Screening all the Danio rerio genome by pattern-matching-based analysis, 
we found p53 RE-like patterns proximal to 979 annotated Danio rerio genes. Prioritization analysis 
identified a subset of 134 candidate pattern-related genes, 31 of which have been investigated in 
further biochemical assays. Our study identified runx1, axin1, traf4a, hspa8, col4a5, necab2, and dnajc9 
genes as novel direct p53 targets and 12 additional p53-controlled genes in Danio rerio genome. The 
proposed combinatorial approach resulted to be highly sensitive and robust for identifying new p53 
target genes also in additional animal species.
The intricate pattern of gene regulation involves the concerted action of both cis- and trans-acting transcription 
factors which bind to short nucleotide regulatory sequences in DNA modulating the expression of physically 
adjacent or very distant, even located on different chromosomes, coding sequences. Transcriptional networks 
evolution depends also on a number of modifications of master regulators (trans-evolution) or changes in 
cis-regulatory sequences (cis-evolution). Among sequence-specific transcription factors, p53 is a master regu-
lator that, in response to stress conditions, coordinates the expression of a large set of target genes involved in a 
number of complex regulatory networks, which fulfil several important biological functions, such as apoptosis1, 
cell cycle regulation2, senescence3, cell differentiation, motility, and migration4–8. As a consequence of the cellular 
homeostasis and microenvironment variations, the level of p53 protein accumulation, the ability to interact with 
other proteins, and DNA binding activity and specificity were all finely tuned.
As a transcription factor, p53 recognizes its target genes by binding to a specific double-strand DNA 
sequence or response element (RE) composed of two palindromic, decameric half-sites of the general form: 
RRRCWWGYYY (where R stands for purine, Y for pyrimidine, W for adenine or thymine) separated by a 0–15 bp 
long spacer9. On the basis of X-ray crystallography of the p53–DNA complex, the 6 nucleotides 5′ -RCWWGY-3′ 
are the most critical ones, which come into close contact with the core DNA-binding domain of the p53 protein10. 
p53 REs can be located anywhere within its target gene locus9, even if most of them are commonly found in the 
promoter region at varying distances upstream the transcription starting site (TSS), as it is the case of p21 and 
noxa genes11.
Differences in RE sequences can strongly impact on the p53 transactivation capacity and occur even between 
closely related species12–16. For instance, human and mouse p53 proteins share a high sequence similarity and 
exhibit analogous biochemical functions and transactivation activity, while they diverge evolutionarily, both 
in terms of the p53 binding site (BS) sequences and, as a consequence, in terms of the p53-transcriptional 
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network15,17,18. Therefore, the identification and characterization of a species-specific p53 BS consensus sequence 
and of the associated target genes may help to provide new insights into the evolution of the p53 regulatory net-
works across different species. Here, we designed and biochemically validated a computational tool to identify 
p53-target genes in Danio rerio (zebrafish). Our approach expanded the number of direct p53 target genes in this 
organism.
Results
In silico similarity search of putative p53-binding sites. A total of 3,033 hits for the RRRCWWGY 
YYN{0, 15}RRRCWWGYYY motif were found in the Danio rerio genome (Table S1), according to the PatMatch 
scanning analysis, with a substantially uniform pattern distribution among the 25 chromosomes (2.25 patterns 
per Mb, on the average). This analysis detected the 47% (1,420 out of 3,033) of the retrieved p53 DNA binding 
sites within repeat or transposable elements of Danio rerio genome. We ranged the spacer size from 0 to 15 bp and 
found a bi-modal frequency distribution, with peaks at 0 and 11 bp. A total of 1,277 gene-related patterns were 
found located in the ± 5 Kb genomic neighbourhood of Danio rerio genes. In some cases, multiple genes resulted 
to be close to the same pattern or multiple patterns were found in the proximity of the same gene (Table 1 and 
S2). Particularly, 1,099 patterns were uniquely mapped to distinct genes, while 178 were proximal to more than 
one gene. Totally, this analysis identified 984 pattern-related genes including 979 protein-coding and 5 miRNAs. 
140 out of 984 Danio rerio genes were associated to more than one pattern. Such genes as arl13a, cetn3, rnf150a, 
runx1, zgc:136572, zgc:158766 have 10 or more motifs within their neighbourhoods. 472 out of 984 genes were 
positioned on the same genomic strand of their corresponding patterns (Table 1). All the genomic features of the 
found patterns are described in Tables S1 and S2.
Thus using the prioritization criteria (see Material and Methods section) (Table S3), along with the infor-
mation about tissue specificity and the position of the patterns relative to the TSS, we selected a subset of 134 
candidate motifs (Table S4).
As a preliminary investigation, we searched human orthologs for 134 prioritized zebrafish genes (Table S4) 
and checked their expression level into p53-related public datasets (Gene Expression Atlas 3.0, access: June 2016, 
https://www.ebi.ac.uk/gxa/home) (Table S5). A considerable proportion of Dr-retrieved gene/human-gene sets 
(53%, 73%, and 15,7% for p53, p53 and cancer, doxorubicin condition queries, respectively) was reported to be 
under- or over-expressed according to different experimental conditions suggesting their possible role as putative 
p53-controlled genes.
p53-binding sites in vitro validation. We randomly selected 10 out of 134 predicted Danio rerio BSs, 
located at varying distances from the TSS of the related gene, for further in vitro validation (Table 2 and Table S6).
First, to assess whether in silico candidate patterns may drive the Drp53-mediated transactivation or repres-
sion, we performed a luciferase-based assay. Short genomic regions harbouring selected Drp53 BSs associated 
to 10 genes (Table 2 and Table S6) were cloned in luciferase reporter plasmids, and transfected into the human 
p53-deficient cell line H129919 along with vectors expressing wild-type Drp53, or an empty vector as a nega-
tive control. All amplified genomic fragments contain only one predicted p53 BS, but the region associated to 
runx1 gene that includes four p53 BSs. A vector containing trim8a p53 REs was used as a positive control19. We 
found that all putative BSs mediate p53-responsiveness (Fig. 1a), although with different strength. Particularly, 
reporter gene activation mediated by Drp53 was stronger for the p53 BSs potentially associated to runx1  
(60 folds), axin1 (25 folds), traf4a (50 folds), and hspa8 (9 folds) genes, when compared to the control. To test 
whether the activation was dependent on functional p53, we used an N-terminal truncated p53 isoform, ∆ 1–113 
Drp53 (pCS2-Drp53Mut), which interferes with the p53 functions20. Consistent with the effect of this truncated 
form of p53, co-transfection of both full-length Drp53 and ∆ 1–113 Drp53 constructs in H1299 cells result in a 
luciferase activity decrease for all analysed BSs, when compared to transfection with full-length Drp53 protein 
only (Fig. 1a).
Next, we generated mutant vectors carrying the deletion of BSs for those genomic fragments that exhibited 
strong reporter gene activation. As showed in Fig. 1b, Drp53 was unable to activate the luciferase reporter gene 
Number of PatMatch patterns 3033
Number of gene-related patterns 1277
Number of unique gene-related patterns 1099
Genes (grouped by tipology) 979 protein-coding, 5 miRNA
Genes with more than one associated pattern 140
Number of reference transcripts 984
Number of patterns in the same orientation of genes 553
Number of genes in the same orientation of patterns 472
Proportion of patterns in 5′ UTR 53/553
Proportion of patterns in upstream regions 73/553
Proportion of patterns within introns 194/553
Proportion of patterns within other gene regions 233
Proportion of gene-related patterns within repeats 254/553
Table 1.  General features of the PatMatch patterns, with a focus on those detected in proximity to the 
Danio rerio genes.
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for all constructs, except for p53-delRE-runx1, which was still responsive to the action of p53, likely because this 
construct still maintains three out of four predicted BSs. To define whether the conserved p53 RE CWWG core 
motif is necessary for reporter activation in Danio rerio as well as in human, we performed luciferase assays by 
using reporter vectors carrying nucleotide changes in the CWWG consensus (Fig. 1c). The results showed that 
replacing the core CWWG of runx1, axin1, traf4a, and hspa8 p53 REs with ACCT sequence the responsiveness to 
p53 was dramatically reduced (Fig. 1d). Taken together, these results revealed that the analysed Danio rerio p53 
BSs are functionally active, being each of them capable of conferring p53-dependent transcriptional activation on 
a luciferase reporter gene. Accordingly to the human p53 RE consensus, the core CWWG motif has a fundamen-
tal role in determining p53 activation function.
In order to confirm the functionality of these p53 BSs we investigated the native binding of endogenous p53 
to the genomic locations where we have identified putative p53 BS. Chromatin immunoprecipitation in wild type 
24 hour Danio rerio embryos (Fig. 1e) confirms that p53 binds to the runx1, traf4a, and hspa8 p53 REs (ChIP). We 
also observed a slight enrichment in the binding to axin1 p53 RE with respect to the control, probably reflecting 
the low level of axin1 expression at this developmental stage. Additionally, we detect clear enrichment of p53 in the 
col4a5, dnajc9, and necab2 p53 REs. This result indicates that the described p53 REs can act as enhancers through 
direct binding of p53 in the predicted binding sites, confirming that these seven genes are direct targets of p53. As 
a positive control for ChIP we analysed the binding of p53 to the p53-responsive element of a previously reported 
Drp53 target gene, puma21. Conversely, we did not find any direct p53 binding in the stat3, vcp, and ttyh2l p53 RE.
To verify if the genes embedding the p53 BSs are per se responsive to the action of p53, we profiled in vivo 
the expression of ten p53 RE associated genes on 54 hpf zebrafish embryos incubated for 16 hours in presence of 
50 µM R-roscovitine, a cyclin-dependent kinase inhibitor that can efficiently stabilize and activate the nuclear 
p53 in human and zebrafish cells22,23. We found that the transcript levels of the genes surrounding the ten p53 
BSs were increased in embryos upon exposure to R-roscovitine, compared to untreated embryos (Fig. 1f). 
Consistently, we observed a reduced mRNA level for all 10 genes in Danio rerio embryos injected with p53 anti-
sense morpholino24, when compared to uninjected embryos (Fig. 1g).
Moreover we evaluated the responsiveness to human p53 of tested Dr BSs. We observed that the human p53 
protein is able to efficiently activate the reporter gene expression (Fig. 1h), while the transactivation defective 
mutant p53-R175H (pcDNA3-MutHsp53) was unable to bind and activate the reporter constructs. Overall, these 
results confirm that p53 REs were responsive to both human and Danio rerio p53 proteins.
PWM-driven similarity search of Drp53-target genes and in vitro validation. Subsequently, by 
using an additional similarity-based motif-search computational strategy we identified a second list of candidate 
p53 pattern-related genes for in vitro validation.
We aligned the nucleotide sequences of the ten responsive elements initially validated by luciferase reporter 
assays (Fig. 2a,b, Table 2) calculating a new PWM (Table S7), which was finally inputted to two popular motif 
analysis resources, MEME and RSAT, and used as seed for an additional pattern similarity search. This strategy 
identified a group of 52 putative p53 pattern-related genes (Table S8), 21 of which were randomly selected for 
further in vitro validation (Table 3).
To verify whether such 21 genes are per se responsive to p53, we performed a gene expression profiling by 
qPCR in 54 hpf Danio rerio embryos incubated for 16 hours in presence of 50 µM R-roscovitine (Fig. 3a) or in 
embryos injected with p53 antisense morpholino (Fig. 3b), finding a significant increase of transcript levels in 
12 out of 21 analysed genes or an mRNA decrease of all genes, respectively, compared to untreated embryos 
(Fig. 3a,b).
# Gene Chr Pattern start Pattern end Position vs TSS Overlap within repeat Note
1 hspa8 10 30761068 30761101 exon9 No Belonging to human P53 network.
2 stat3 3 16723031 16723052 intron22–23 No
High rank by both prioritization tools, but 
pattern is not located in canonical regions 
(within the 4–5th intron).
3 axin1 3 43009715 43009734 intron5–6 Yes hAT-N54_DR High rank by both prioritization tools; pattern in repeat element
4 vcp 5 43134399 43134429 intron8–9 Yes hAT-N52_DR High rank by both prioritization tools; Pattern partially in repeat element
5 runx1 1 1067563 1067595 intron2–3 No High rank by both prioritization tools; Multiple patterns in the region
6 dnajc9 12 10255976 10256007 upstream No Plausible pattern position with respect to TSS; expressed in central nervous system.
7 traf4a 15 14555737 14555756 5′UTR No Plausible pattern position with respect to TSS; expressed in central nervous system.
8 necab2 18 21197526 21197546 upstream No Plausible pattern position with respect to TSS ; expressed in central nervous system.
9 ttyh2l 3 52217686 52217707 upstream No Plausible pattern position with respect to TSS; expressed in neural tube.
10 col4a5 7 52559622 52559647 upstream No Plausible pattern position with respect to TSS; expressed in diencephalon.
Table 2.  General features of the first 10 Drp53 BSs: gene symbol, motif location, position with respect to 
the gene TSS, presence within repeat element and gene functional details are reported.
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Figure 1. Danio rerio genes-embedded p53 BS show p53–dependent transactivation. (a) p53-null H1299 
cells were cotransfected with reporter constructs carrying the predicted p53 RE of selected genes (pGL3_wtRE), 
Drp53 expression vector (pCS2-Drp53), an N-terminal truncated Drp53 isoform, ∆ 1–113 Drp53 (pCS2-
Drp53Mut), or pCS2 as a negative control. A vector containing trim8a-RE was used as a positive control.  
(b) p53-null H1299 cells were cotransfected with reporter constructs carrying or lacking the p53 REs (pGL3_
wtRE or delRE of runx1, axin1, traf4a, and hspa8, respectively) and pCS2-Drp53 or pCS2 as a negative control. 
(c) Schematic representation of pGL3 vectors carrying wild type (pGL3_wtRE) or mutated CWWG p53 RE 
(pGL3_pmRE, pm: point mutation) of runx1, axin1, traf4a, and hspa8 genes. (d) p53-null H1299 cells were 
cotransfected with reporter carrying the wild type or mutated CWWG p53 REs of analyzed genes (pGL3_wtRE 
or pGL3_pmRE) and pCS2-Drp53 or pCS2 as a negative control. (e) ChIP analyses were carried out with 
anti-p53 antibody on 24 hpf embryos. The p53 RE in puma is the positive control, H3 (line 3) and IgG (line 4) 
are the positive and negative controls of the immunoprecipitation, respectively. Loading marker (line 1). The 
data presented are representative of three independent experiments. (f,g) qPCR analyses were carried out on 
ten p53 pattern-related genes in 54 hpf embryos incubated with 50 µM R-roscovitine (f) and in 30 hpf embryos 
injected with p53 MO (g), compared to untreated embryos (horizontal black line). The data were normalized 
to the expression of topI. The expression of bax, p2122,61, puma62 and trim8a19 was measured as positive controls 
(grey bar). Bar represents the average of three independent experiments ± standard error. *P < 0.05. (h) p53-
null H1299 were cotransfected with reporter constructs carrying the predicted genes p53 REs (pGL3_wtRE) 
and human p53 expression vector (pcDNA3-Hsp53) or transactivation defective mutant p53R175H (pcDNA3-
Hsp53Mut) or empty control vector (pcDNA3) as a negative control. A vector containing trim8a p53 RE 
was used as a positive control. (a,b,d,h) Luciferase activities were normalized to the level of control Renilla 
luciferase. Each bar represents the average of three independent experiments ± standard error.
www.nature.com/scientificreports/
5Scientific RepoRts | 6:32474 | DOI: 10.1038/srep32474
We also investigated the effects of our computational strategy for pattern prioritization by constructing two 
additional matrices and comparing results obtained. We randomly chose other two sets of sequences from the 
list of 134 candidate genes (Table S4) and created two further PWMs (Fig. 4 and Table S7). The selected patterns 
(Table S4, columns “PWM-II” and “PWM-III”) were analysed with the same combined strategy of motif simi-
larity search, MEME and RSAT, applied to the first PWM, which was obtained from the first 10 validated motifs. 
Comparing the results obtained with the three PWMs, we found that 12 and 17 out of the 52 selected patterns 
(which are those with at least one significant similarity score calculated by the first PWM) were obtained when 
applying the two methodologies on the PWM-II, respectively. The analysis of the third PWM yielded, instead, 22 
and 21 patterns from MEME and RSAT implementation, respectively (Table S8). The whole computational and 
biochemical analysis workflow is summarized in Fig. 5.
Ingenuity Pathway Analysis. All 31 genes were systematically analyzed by Ingenuity Pathway Analysis 
in search of over-represented functional processes. As from Fig. 6, we verified a significant representation of 
neuronal (neuronal cell death, p-value = 2.86E-03; differentiation of nervous system, p-value = 5.81E-04; 
development of neurons, p-value = 1.05E-03), metabolic (metabolism of protein, p-value = 5.60E-03), gene 
expression-related (transcription of DNA, p-value = 4.51E-03) and cancer-related (apoptosis of tumour cell lines, 
p-value = 3.32E-03, apoptosis, p-value = 4.88E-03, malignant solid tumour, p-value = 1.01E-03, invasion of cells, 
p-value = 5.68E-04) processes.
The functional role of all the 31 investigated genes is summarized in Table S9, in which, for each gene, Gene 
Ontology Accession numbers and Terms have been reported.
Discussion
The capacity of transcriptional regulatory machinery to quickly bring about changes in the gene expression 
pattern allows organisms to adapt to environmental and genetic changes. Transcription factor binding sites are 
generally known to evolve more rapidly than transcription factors themselves, playing a crucial part in the phe-
notypic divergence between and within closely related species25,26.
The binding of p53 with the DNA represents the crucial step by which the so-called “guardian of the genome” 
coordinates and regulates a wide set of downstream target genes. Because of the degenerate nature of the con-
sensus p53 RE, changes in the level of p53 responsiveness have been observed and the rapid evolution of these 
regulatory elements determines variations in the p53 network between and within species13.
Therefore, the characterization of species-specific p53 BSs and target genes may help to provide insights into 
the evolution of p53 regulatory networks and to understand species-specific differences in several biological 
processes.
Here, we designed and biochemically validated a computational analysis that allowed us to identify novel p53 
target genes in Danio rerio genome, an organism model widely used in human diseases and cancer, for whom 
little is known about the Drp53-mediated transcriptional signature.
Figure 2. Nucleotide sequence alignment of the tested Danio rerio p53 binding sites. (a) Consensus 
sequence and the degree of conservation of each alignment site are shown on the bottom part of the alignment. 
(b) Consensus sequence logo has been created by using the WebLogo tool: http://weblogo.berkeley.edu/logo.
cgi63. A total of 52 patterns were retrieved by MEME and RSAT motif similarity search (details shown in 
Supplementary Table S4).
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Screening all the Danio rerio genomic contexts by pattern-matching-based analysis, we found a total of 3,033 
matching p53 RE-like patterns with 1,099 of them proximal to the annotated Danio rerio genes. In this analysis 
47% (1,420 out of 3,033) of the retrieved patterns were detected within repeat or transposable elements in Danio 
rerio genome, as previously reported in ref. 19. In particular, the query pattern partially matched the elements 
belonging to the hAT-AC (30% of the total pool) and DNA (14%) repeat families or to the TE-X-4_DR trans-
posable element (14%). These elements can promote the spread of p53 BSs, thereby contributing to the diversity 
of the p53 response between and within species, including p53-influenced processes, such as tumour formation, 
longevity, angiogenesis and fertility27–29.
Among the predicted gene-related patterns, we selected 10 binding sites and 10 matching pattern-related 
genes for in vitro validation using luciferase and qPCR assays, respectively, confirming their responsiveness to 
both Drp53 and Hsp53. ChIP assays, performed in wild type 24 hours Danio rerio embryos, confirm that p53 
directly binds to the runx1, traf4a, axin1, hspa8, col4a5, dnajc9, and necab p53 RE indicating that these genes 
can be considered as bona fide direct targets of p53. Drp53 was not detected to stat3, vcp, and tty2l p53 RE that 
exhibited the lowest level of gene reporter activity for both Drp53 and Hsp53.
The failure to detect direct binding of p53 to some of the p53 RE such as stat3, vcp, and tty2l might be due to 
technical issues such as low affinity sites, absence of cofactors or developmental stage as is shown by the low level 
of reporter activity for both Drp53 and Hsp53.
Notably, we observed a difference in reporter gene activation between human and zebrafish p53. This could 
be due to several reasons: i) Drp53 REs were searched by using the human motif as starting query. It is thus con-
ceivable that the selected Drp53REs could be more specific for human p53 binding with respect to Drp53; ii) the 
Drp53 and Hsp53 are temperature sensitive proteins exhibiting their optimal activities at 28 °C and 37 °C, respec-
tively, with Drp53 displaying no transactivation or very weak activation at 37 °C19; iii) we carried out the luciferase 
assays in human cells cultured at 28 °C, which is not the standard condition for cell growth.
The validated pattern-gene pairs were subsequently used as seed for an additional similarity-based 
motif-search strategy that identified a second list of putative p53 targeted genes, among which we randomly 
chose 21 for further validation. We profiled their expression by qPCR both in Danio rerio embryos either silenced 











1 acp6 9 31514159 31514188 intron3–4 − Pattern significantly similar to PWM.
2 atf4b1 6 214982 215012 upstream − Pattern significantly similar to PWM. Multiple patterns within the region.
3 cab39 15 38611426 38611457 upstream − Pattern significantly similar to PWM
4 cmah 4 2087845 2087866 upstream − Pattern significantly similar to the PWM  (only with MAST tool)
5 ctsh 18 26206107 26206126 upstream Pattern significantly similar to PWM (only with MAST tool). Within the top50 ranking genes according ToppGene.
6 dnai2a 12 37713739 37713769 upstream − Pattern significantly similar to PWM
7 eng2b 2 29688318 29688343 intron3–4 − Pattern significantly similar to PWM. Expressed in whole organism, and, in particular, nervous system.
8 frem2b 15 33324401 33324435 upstream − Pattern significantly similar to PWM (only with MAST tool)
9 fut8 17 34073168 34073189 intron1–2 − Pattern significantly similar to PWM. Expressed in whole organism.
10 lnx1 20 22699415 22699434 intron2–3 − Pattern significantly similar to PWM
11 itm2bb 9 26365976 26366010 intron3–4 − Pattern significantly similar to PWM. Expressed in whole organism.
12 kcnk9 19 5317791 5317810 intron1–2 − Pattern significantly similar to PWM (only with RSAT).
13 mfge8b 25 19639397 19682265 upstream − Pattern significantly similar to PWM (only with MAST tool)
14 pak4 15 24783195 24817101 intron2–3 − Pattern significantly similar to PWM (only with MAST tool). Within the top50 ranking genes according Endeavour.
15 pcyt1aa 2 9548952 9548972 upstream − Pattern significantly similar to PWM (only with MAST tool).
16 prosc 23 34273590 34273621 upstream − Pattern significantly similar to PWM
17 pspc1 1 26770983 26771015 upstream − Pattern significantly similar to PWM
18 ptgs1 5 68489605 68489628 upstream − Pattern significantly similar to PWM. Within the top50 ranking genes according ToppGene.
19 tpc3 11 31521673 31521704 intron2–3 − Pattern significantly similar to PWM
20 ubap2l 19 8381258 8381282 upstream − Pattern significantly similar to PWM
21 wbp1la 13 28803993 28804014 upstream − Pattern significantly similar to PWM (only with MAST tool).
Table 3.  General features of additional 21 candidate Drp53 BSs. Gene symbol, motif location, position with 
respect to the gene TSS, and presence within repeat element are described. Considerations on pattern similarity 
to the PWM, tissue expression, and functional annotation are also reported.
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Figure 3. In-vivo Drp53 exhibited transactivation potential on p53 REs-embedded genes. (a) qPCR was 
performed to measure the expression of twenty-one additional potential Drp53 target genes on Danio rerio 
54 hpf embryos incubated with 50 µM R-roscovitine, compared to untreated embryos (horizontal black 
line). An increase of transcript levels in 12/21 analyzed genes was observed, compared to control embryos. 
(b) twenty-one candidate genes associated to Danio rerio p53 RE on 30 hpf embryos injected with p53 
antisense morpholino compared to embryos uninjected, setting the threshold to one. A mRNA decrease of 
all twenty-one analysed genes was found. (a,b) The result obtained for all candidate genes was normalized to 
the expression of top I. Bar represents the average of three independent experiments and scale bars represent 
standard errors. *P < 0.05.
Figure 4. Generation of PWM-II and PWM-III matrices. Nucleotide sequence alignments and DNA logos 
deriving from the two additional motif sets (see Materials and Methods; details also in Tables S4 and S7).
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Therefore, we cannot exclude the possibility that the other 9 genes, which are significantly deregulated in 
Danio rerio embryos that were injected with p53 antisense morpholino, but not in embryos treated with 
R-roscovitine, could be regulated by Drp53.
Many factors could contribute to the differential transactivation to p53 observed in our assayed genes. 
Post-transcriptional and post-translational modifications of p53, recruitment of co-factors (co-repressors/
chromatin-modifying factors), competition with transcription activator for DNA-binding site30, cellular and 
genomic context31, chromatin state, complexity of transcriptional regulation in living cells, features of the RE 
sequences, which take into account, i.e., of the variability of the spacer lengths, and the response variability 
upon each different p53 stimuli, as well as the R-roscovitine that interferes with the preferential activation of 
some p53-target genes, are possible causes. Regarding the latter point, we observed that the expression of dnai2a 
and mfge8b was down regulated in both R-roscovitine-treated and p53-antisense-injected embryos (Fig. 3a,b). 
Figure 5. The experimental flowchart for the identification of the Drp53 pattern-related target genes. 
Rectangular boxes summarize the analysis steps described in the Material and Methods section. Parallelograms 
represent the data flow.
Figure 6. Functional network of 31 Drp53 putative target genes. Arrows linking genes or connecting genes 
to biological processes indicate reported evidences of interaction or functional participation, respectively. 
An exhaustive legend of symbols is available at: http://ingenuity.force.com/ipa/articles/Feature_Description/
Legend.
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Probably, a different p53-dependent transactivation of some genes could be observed in response to several 
DNA-damaging reagents activating specific p53 transcriptional programs.
Collectively, our analysis identified 7 novel p53 target genes: runx1, axin1, traf4a, hspa8, col4a5, necab2, and 
dnajc9. Interestingly, the p53 target genes identified in this study appear to involve broad functional classes and 
multiple gene families that are related, directly or indirectly, to the p53 pathway in human.
Human RUNX1 is a member of the RUNX transcription factor family that play essential roles in the vertebrate 
embryo by directly regulating transcription in a variety of developmental pathways including neurogenesis, bone 
development, and segmentation32. Runx1 has also an important role during hematopoiesis in fish as in mouse and 
human33. Interestingly, Masse et al. reported that a functional interplay between p63 and p53 regulates RUNX1 
expression in the control of the transition from proliferation to early differentiation in human keratinocytes34.
TRAF4 is a member of the TRAF family of adaptor proteins that mediate cellular signalling by binding to 
various members of the tumour necrosis family receptor superfamily and interleukin-1/Toll-like receptor 
super-family. The analysis of traf4-deficient mice revealed embryonic lethality underlying its potential impor-
tance during embryogenesis35. TRAF4 is specifically regulated by p53 in response to overexpression of p53 by use 
of an adenovirus and stabilization of p53 in response to exposure to DNA-damaging agents. The murine Traf4 
genomic locus contains a functional p53 DNA-binding element located approximately 1 kilobase upstream of the 
translation start site. Overexpression of TRAF4 induces apoptosis and suppresses colony formation in multiple 
tumour cell lines suggesting a role for TRAF4 in determining cell fate in response to stabilization of p5336. Danio 
rerio ortholog traf4a shows a highly restricted expression pattern mainly in sensorial and neural cells, and in 
somites of Danio rerio embryos37.
Axin1 is a negative regulator of axis formation in the development of mouse embryos. Its deficiency leads 
to axis duplication38 and its overexpression blocked embryo axis formation in Xenopus and caused apoptosis in 
transgenic mice39,40. Accumulating data showed that Axin1 controls multiple important pathways, including the 
canonical Wnt pathway, JNK signaling, TGF-β signalling, and p53 activation cascade41–43.
A large variety of cellular functions have been attributed to heat shock protein HSPA8, most of them through 
its cooperation with cochaperones like its role as a clathrin-uncoating ATPase during clathrin-mediated endo-
cytosis. HSPA8 is also a major actor in chaperone-mediated autophagy and its involvement in protein import 
into organelles or cellular compartments has been the focus of numerous studies. HSPA8 has been identified as a 
p53-repressed target44. p53 binds a direct specific sequence on the HSPA8 promoter followed by p53-dependent 
recruitment of Sin3B/HDAC1 co-repressor complex as well as hyper-methylation. On the other hand, HSPA8 
repression is critical for the functional activation of p53 because Hspa8 protein is known to antagonize the p53 
nuclear localization by masking the nuclear localization signal sequence of p5345.
In conclusion, the approaches described here illustrate the great advantage of combining global p53 
DNA-binding site in silico analysis and molecular assays, providing an efficient strategy to identify new p53 Danio 
rerio REs and target genes.
The identification and characterization of a Danio rerio-specific p53 BS consensus sequence and of the associ-
ated target genes may help to provide new insights into the evolution of the p53 regulatory networks in determin-
ing phenotypic diversity among species.
Materials and Methods
Pattern searching in Danio rerio genome. The first step of our computational strategy, which we have 
set up to identify the potential motifs of the p53 responsive elements in Danio rerio, encompasses the search of 
the human motif RRRCWWGYYYN{0, 15}RRRCWWGYYY in the Danio rerio genome. The build Zv9/danRer 
7 version, July 2010, was considered as the reference genome (available at ftp://ftp.ensembl.org/pub/release-79/
fasta/danio_rerio/dna/)46, from which we retrieved the genomic coordinates of the genes and of the repeat/trans-
posable elements.
The pattern-matching tool initially used was PatMatch 1.2 (available at ftp://ftp.arabidopsis.org/home/tair/
Software/)47. It implements an exact matching algorithm. It was run with this command line:
perl patmatch.pl -n “RRRCWWGYYYN{0, 15}RRRCWWGYYY” Zv9.fasta.prepared > patmatch_Zv9_patterns.out, 
where the argument “-n” defines the pattern, while the “prepared” fasta file consists of the input genomic 
sequences (strand ‘ + ’), manipulated as required by the tool. The expression “{0, 15}” indicates the spacer size. 
PatMatch produced a tabular output, containing all the nucleotide sequences that matched the pattern, together 
with the associated chromosomal coordinates. Results obtained by PatMatch were confirmed with p53scan 
1.05 (available for download at www.rimls.nl/bioinfo/p53scan/)48. This tool implements a position weight 
matrix-based pattern-finding algorithm and uses a probabilistic approach that associates every matching site to 
a multinomial distribution (site-specific relative nucleotide frequencies, as defined by the p53scan PWM), rather 
than a single character state (one of the four nucleotides). It was run on the human p53 binding-site position 
weight matrix (PWM) accompanying the software package, by setting a spacer size ranging from 0 to 15. The 
command line was:
python p53scan.py -i Zv9.fasta -s 0-15 > p53scan_Zv9_patterns.out, where “Zv9.fasta” specifies the Danio rerio 
reference genome, while the “-s” parameter sets the allowable sizes of the p53 motif spacer.
Then, we explored the genomic context of each found pattern by choosing 5 Kb up and downstream follow-
ing48–50 and focused only on contexts that included at least one annotated gene, according to the Zv9 reference 
gene coordinates. For each gene, we collected NCBI and Ensembl accession numbers, gene official symbol, CDS 
and exons coordinates, associated Gene Ontology terms via the Biomart query tool51. We thus annotated them 
in order to improve the sensitivity of the overall analytical strategy. First, we checked if putative target genes were 
located on the same genomic strand of the retrieved patterns. Considering also the distance from the TSSs, we 
labelled the patterns with the gene regions where they fell in (i.e., promoter, UTR, exon and intron).
www.nature.com/scientificreports/
1 0Scientific RepoRts | 6:32474 | DOI: 10.1038/srep32474
Hence, the Homo sapiens orthologs of all the genes falling within the ± 5 Kb up/down-stream genomic context 
of each pattern were searched in Ensembl 78, through Biomart, taking care of specifying that these were Danio 
rerio Ensembl Gene IDs. Homology relationships were obtained by extracting the gene trees of interest from the 
Ensembl Compara pre-computed phylogenies. The output consisted in a list of pairs of Ensembl Human Gene 
ID and Homology Type, comprising of only homolog genes with a one-to-one relationship. Among the different 
options of orthology predictions (“one2one”, “one2many”, “many2many”), we opted for the former, hypothesiz-
ing that such relationship should preserve the functional similarity of orthologs between Danio rerio and Homo 
sapiens.
Then, the resulting human ortholog genes were prioritized according to their functional proximity to 127 
renowned p53-regulated human genes (Table S3), obtained from Riley et al.9. This set of 127 genes was basically 
used as training dataset for two gene prioritization bioinformatics tools: Endeavour52 and ToppGene53, which 
were run with default settings. We then considered the first 50 genes, which exhibited the most significant overall 
scores by Endeavour or ToppGene (Table S3).
In addition, information on gene expression was retrieved from the Zfin web resource54 by searching for tissue 
expression data for wild type organisms, from zygote to adult samples, through the “Expression” menu of the 
main page of the tool.
In summary, we first collected genomic and functional data related to each discovered “pattern-gene” pairs 
and then, we manually curated the selection of a limited number of them for in-vitro/in-vivo validation.
Cloning of Danio rerio p53 binding sites, site-directed mutagenesis and dual-luciferase assay. 
Fragments of approximately 300–500 bp containing the predicted p53 BS were amplified by polymerase chain 
reaction (PCR) using a Danio rerio genomic DNA as template and then cloned into pGL3-basic vector (Promega). 
All constructs were verified by sequencing.
The human lung adenocarcinoma p53-null cell line H1299 was grown in DMEM medium supplemented 
with 10% fetal bovine serum (FBS; Life Technologies, USA) and 1% antibiotics mixture in a 37 °C incubator 
with 5% CO2. The reporter construct, p53 expression vector (pCS2-Drp53 or pcDNA3-Hsp53) or mutant p53 
expressing vector (pCS2-Drp53Mut or pcDNA3-Hsp53Mut, an N-terminal truncated p53 isoform, ∆ 1–113 
Drp53, that lacks the transcription activation domain) or empty control vector, and pSV-Renilla (Promega) were 
co-transfected into p53-null H1299 cells plated in 96-well plates using Lipofectamine® LTX with Plus™ Reagent 
(Life Technologies) according to the manufacturer’s instructions. Since it was previously reported that Drp53 is a 
temperature sensitive protein18, cells were grown at 28 °C and 37 °C when transfected with pCS2-Drp53 or pcD-
NA3-Hsp53 respectively. 48 h after transfection, cells were washed with PBS, lysed and assayed for both Firefly and 
Renilla luciferase activity using the Dual-GLO® Luciferase Assay System (Promega) by a Glomax 96 microplate 
luminometer. Firefly luciferase activity was normalized to the Renilla luciferase activity for each transfected well, 
as reported in ref. 19. Constructs changing the p53 BS were generated by QuickChange II site-directed mutagen-
esis kit (Stratagene). The primer pairs used are listed in the Table S10.
Chromatin immunoprecipitation. ChIP experiments were carried out following the EZ-Magna ChiP 
A/G Chromatin Immunoprecipitation Kit (Merck-Millipore) protocol essentially as described in ref. 21. Briefly, 
30 dechorionated embryos (24 to 34 hour after fertilisation, AB strain) were fixed for 10 minutes in 1% formal-
dehyde, washed and sonicated in 300 µ l of lysis buffer. Chromatin was immunoprecipitated with the anti-p53 
antibodies kindly provided by Prof. G. Del Sal (University of Trieste, Trieste, Italy). The positive and negative 
controls were Rabbit anti-H3 (Abcam) and Rabbit anti-IgG (Diagenode) respectively. PCRs were performed with 
the Kapa 2G Fast HS (Kapa Biosystems) with the oligonucleotides indicated in Table S10. The data presented are 
representative of three independent experiments.
Zebrafish care. Wild-type zebrafish (Danio rerio, AB type) embryos were obtained by natural spawning and 
were raised under standard conditions at 28 °C, with a 14-hour light/10-hour dark cycle in fish water (0.1 g/L 
Instant Ocean Sea Salts, 0.1 g/L sodium bicarbonate, 0.19 g/L calcium sulphate, 0.2 mg/L methylen blue, H2O) 
until the desired developmental stage was reached.
Embryos were staged according to Kimmel et al.55 and developmental stages of zebrafish embryos were 
expressed as hpf or dpf (hours or days post- fertilization, respectively) at 28 °C. This study has been approved by 
OPBA (Organismo Preposto al Benessere degli Animali) of the Ethics Committee of the University of Brescia. 
The use of the teleost fish Danio rerio – zebrafish - for the study of human disease has been approved by Ministry 
of Health. Animal experiments were carried out according to the relevant guidelines and regulations of the EU 
Directive 2010/63/EU.
Morpholino injection. p53 Morpholino Oligo (MO) (GeneTools LLC, Philomath, OR, USA) targeting 
p53 zebrafish translation start site was used (GCGCCATTGCTTTGCAAGAATTG). p53 MO was diluted in 1x 
Danieau buffer (pH 7.6) and 2.5% tetramethylrhodamine dextran (Molecular Probes) as a tracer. 0.5 pmol of p53 
expression–inhibiting morpholino were injected into the yolk of 1–2 cell stage embryos as previously reported24,56. 
Embryos were then raised until 30 hpf and processed for RNA extraction as described below. Injections were 
repeated three times; 100 embryos were injected and processed in every experiment. Non-injected embryos were 
used as negative control.
Roscovitine treatment, RNA isolation and quantitative PCR. 54 hpf Danio rerio embryos were incu-
bated in fish water containing 50µ M R-roscovitine (Calbiochem) or 0.1% (v/v) DMSO for 16 hours at 28 °C. 
Embryos were then grown for 8 more hours in absence of roscovotine, harvested, washed in PBS-DEPC and cryo-
conserved at − 80 °C before performing the RNA extraction. Total RNA was extracted by using RNeasy® Mini 
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kit (Qiagen) and reverse transcribed using QuantiTect® Reverse Transcription Kit (Qiagen), according to the 
manufacturer’s instructions. The expression levels of putative genes associated to p53 BS were examined by quan-
titative PCR (qPCR). The primer pairs were designed using the primer express software package57 with default 
parameters (Table S10). top1 was used as housekeeping gene (Table S10). The reactions were run in triplicate in 
10 µ l of final volume with 10 ng of sample cDNA, 0.3 mM of each primer, and 1x Power SYBR Green PCR Master 
Mix (Termo Fisher Scientific-Applied Biosystems). Reactions were set up in a 384-well plate format with a Biomec 
2000 (Beckmann Coulter) and run in an ABI Prism 7900HT (Termo Fisher Scientific-Applied Biosystems) with 
default amplification conditions. Raw Ct values were obtained using SDS 2.4.1 (Termo Fisher Scientific-Applied 
Biosystems). Calculations were carried out according to the comparative Ct method as reported in ref. 19.
Identification of additional potential targets by pattern similarity search. The validated 
pattern-gene pairs were subsequently used as seeds for an additional similarity-based motif-search computa-
tional strategy. In detail, by using the CLC Sequence Viewer 7.5 program (http://www.clcbio.com/products/
clc_sequence_viewer/), we aligned the nucleotide sequences of the responsive elements initially validated by 
luciferase reporter analysis. Therefore, since the consensus sequence of the p53 RE is degenerate, we used the 
aligned sequences to construct two new positional weight matrices (PWMs), one for each decamer, which were 
finally inputted to two popular motif analysis resources: MEME58 and the Regulatory Sequence Analysis Tools 
(RSAT)59. We run MAST 4.9.1 of the MEME suite with default parameters on both decamers, separately. MAST 
returned a series of top scoring input sequences, ordered by increasing E-values (i.e., the expected number of 
sequences in a random database of the same size that would match the motifs as well as the sequence, with 10 as 
cut-off value). In addition, we used the “matrix-scan QUICK” method of the RSAT with default parameters. The 
Danio rerio-specific nucleotide frequencies were used as background. As a result, we selected the best significant 
(i.e., p-value < 0.05) “input matrix vs. input sequence” alignments. The sites involved in the pairwise alignments 
were the alignment positions “1–10” or “24–34”. Finally, we crossed the top-ranked binding sites obtained with 
the two tools and made a second list of candidate patterns for in-vitro validation. This procedure was applied to 
two further matrices, built on 20 randomly selected patterns picked from the list of 52 “prioritized” patterns/
genes. With this approach, we evaluated the degree of consistency of the results obtained with MEME and RSAT, 
when applied on the three PWMs, as well as the influence of the matrix-specific compositional features in the 
calculation of pattern similarity scores.
Validated genes were subjected to in-silico functional enrichment analysis by Ingenuity Pathway Analysis 
(IPA; QIAGEN, Redwood City, CA; www.qiagen.com/ingenuity). The procedure was based on the prior calcula-
tion of the activation z-scores, which were used to infer the activation states of the predicted biological functions. 
An enrichment score (Fisher’s exact test, p-value) was calculated to measure the overlap between observed and 
predicted functions60. A function was considered to be significantly over-represented by a set of genes if the cor-
responding p-value < 0.05.
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